Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Ardagh Metal Packaging (AMBP) Stock Is Moving Today: Key Catalysts Investors Should Know

Ardagh Metal Packaging reports 9.73% dividend yield with strong 2025 EBITDA growth of 10%, guiding FY2026 to $750-775M despite North America transition headwinds.AMBP | Dividend Yield: 9.73% | Price: $4.06 USD | Market Cap: $2.43BKey HighlightsFull-year 2025 Adjusted EBITDA reached $739 million, growing 10% …

Vinay Lochav | 13 March 2026

AFC Gamma (AFCG) Stock: Cannabis Lender Navigating Regulatory Uncertainty

AFCG stock trading at $2.63 with 17.76% dividend yield. Cannabis lending specialist with conversion to BDC. Is AFCG a good investment?AFCG | Dividend Yield: 17.76% | Price: $2.63 USD | Market Cap: 61.88M USDKey HighlightsInstitutional lender specializing in secured debt capital for state-licensed cannabis …

Vinay Lochav | 13 March 2026

Why Artisan Partners (APAM) Stock Is Moving Today: Key Catalysts Investors Should Know

Artisan Partners reports $185.3B AUM in January 2026, 9.40% dividend yield, with Q4 2025 revenue beating estimates by 3.7% and operating margins expanding 400 basis points.APAM | Dividend Yield: 9.40% | Price: $35.20 USD | Market Cap: $2.84BKey HighlightsQ4 2025 revenue of $335.5 million …

Vinay Lochav | 13 March 2026

Why Alight Inc (ALIT) Stock Is Moving Today: HR Tech Recovery Narrative Emerges Amid Challenges

ALIT stock analysis: HR/benefits cloud-tech firm facing goodwill impairment recovery. Explore operational challenges, restructuring plans, and 2026 turnaround outlook for investors.ALIT | Dividend Yield: 17.63% | Price: $0.9626 USD | Market Cap: 507.78M USDKey HighlightsReported $3.12 billion goodwill impairment in 2025 reflecting valuation pressures …

Vinay Lochav | 13 March 2026

Why Acco Brands (ACCO) Stock Is Moving Today: Key Catalysts Investors Should Know

ACCO is a branded office supplies leader with 8.82% dividend yield. Q4 results hit expectations but 2026 guidance misses consensus, signaling industry headwinds.ACCO | Dividend Yield: 8.82% | Price: $3.40 USD | Market Cap: $306.58M USDKey HighlightsLeading branded office and school supplies manufacturer with …

Vinay Lochav | 13 March 2026

Why AllianceBernstein (AB) Stock Is Moving Today: Key Catalysts Investors Should Know

AB is a global asset manager with 8.90% dividend yield and $875B AUM. Growth in active ETFs and private markets offset redemptions in traditional active equities.AB | Dividend Yield: 8.90% | Price: $37.96 USD | Market Cap: $3.5B USDKey HighlightsGlobal asset manager with $875 …

Vinay Lochav | 13 March 2026

Abacus Global Management (ABX) Stock Profile: Alternative Asset Manager, 2.03% Dividend Yield and Growth Strategy

Discover Abacus Global Management (ABX) - an alternative asset manager with 2.03% dividend yield, $3.3B in AUM, and $5B growth targets for 2026.ABX | Dividend Yield: 2.03% | Price: $9.85 USD | Market Cap: 962.87M USDKey HighlightsAbacus Global is an alternative asset manager with …

Vinay Lochav | 13 March 2026

Why Icon Energy Corp. (ICON) Stock Is Moving Today: Key Catalysts Investors Should Know

Icon Energy Corp (ICON) stock analysis: shipping company operating dry bulk vessels. Current price $1.19 with 117.65% dividend yield. Latest news and market outlook.ICON | Dividend Yield: 117.65% | Price: $1.19 USD | Market Cap: $3.5MKey HighlightsIcon Energy operates three dry bulk vessels serving …

Vinay Lochav | 13 March 2026

Why Alliance Resource Partners (ARLP) Stock Is Moving Today: Key Catalysts Investors Should Know

ARLP operates coal mining and royalties business with 8.74% dividend yield. Strong production guidance for 2026 drives investor interest in this energy infrastructure MLP.ARLP | Dividend Yield: 8.74% | Price: $27.24 USD | Market Cap: $3.50B USDKey HighlightsSecond-largest eastern US coal producer with seven …

Vinay Lochav | 13 March 2026

Digital Biology: The Next Technological Revolution Reshaping Drug Discovery

The global pharmaceutical industry has historically relied on a slow and uncertain discovery process. Drug development often takes more than a decade and costs billions of dollars. Most experimental molecules fail before reaching the market.

Nitish Kishor | 13 March 2026
Support

Hi! How can we help you today?

Loading…